Leadership
OcuTerra is led by a team with significant biotechnology entrepreneurial and ophthalmology drug development experience and supported by the field’s leading scientific and clinical advisors.
Team
Kerrie Brady, BPharm, MS, MBA
Chief Executive Officer & President
D. Scott Edwards, PhD
Chief Development Operations Officer
David J. Tanzer, MD
Chief Medical Officer
Board of Directors
Brent Saunders, JD
Chairman
William H. Koster, PhD
Vice Chair
Kerrie Brady, BPharm, MS, MBA
CEO & President
Robert Ruffolo, PhD
Board Member
Barbara Ryan
Board Member
Robin Steele, JD
Board Member
Scientific Advisory Board
David S. Boyer, MD
Advisory Board Member
Peter Kaiser, MD
Advisory Board Member
Richard Lindstrom, MD
Advisory Board Member
Jeffrey S. Heier, MD
Advisory Board Member
Paul Karpecki, OD, FAAO
Advisory Board Member
Sheri Rowen, MD
Advisory Board Member
Learn more about
